Australian Paediatric Surveillance Unit (APSU) Annual Surveillance Report 2025 [0.03%]
2025年澳大利亚儿科监测单位(APSU)年度监测报告
Suzy Teutsch,Carlos Nunez,Anne Morris et al.
Suzy Teutsch et al.
For over 30 years, the Australian Paediatric Surveillance Unit (APSU) has conducted national prospective surveillance of rare conditions in children, including communicable diseases and complications, providing data that has informed change...
Creutzfeldt-Jakob disease surveillance in Australia: update to 31 December 2025 [0.03%]
澳大利亚人类克雅二氏病监测至2025年12月31日的最新报告
Christiane Stehmann,Matteo Senesi,Shannon Sarros et al.
Christiane Stehmann et al.
Nationwide surveillance of Creutzfeldt-Jakob disease (CJD) and other human prion diseases is performed by the Australian National Creutzfeldt-Jakob Disease Registry (ANCJDR). National surveillance encompasses the period since 1 January 1970...
Neisseria gonorrhoeae notifications, resistance and management in the Pilbara Region, Western Australia, July 2023 - June 2024 [0.03%]
2023年7月至2024年6月皮尔巴拉地区淋病感染报告、耐药性和管理情况（包括堪培拉地区）
Simon Slota-Kan,Pauline Glasson,Katherine Black
Simon Slota-Kan
Background: In October 2024, Pilbara treatment guidance for uncomplicated urogenital gonorrhoea shifted from routine ZAP pack (amoxicillin 3 g and probenecid 1 g and azithromycin 1 g oral as a single treatment) to ceftria...
Enhanced surveillance for hepatitis B and C: insights into clinical care after diagnosis [0.03%]
改进乙肝和丙肝的监测工作：诊断后的临床治疗新见解
Jennifer MacLachlan,Nicole Romero,Nasra Higgens et al.
Jennifer MacLachlan et al.
Background: There are known gaps in care uptake for hepatitis B virus (HBV) and hepatitis C virus (HCV) infection, and public health surveillance represents an opportunity to support health service engagement for cases; h...
Dharshi Thangarajah,Justin Waring,Justin Denholm et al.
Dharshi Thangarajah et al.
In 2020, the National Notifiable Diseases Surveillance System received 1,618 tuberculosis (TB) notifications, representing a notification rate of 6.3 per 100,0000 population. In 2019, there were 1,505 TB notifications, with a rate of 5.9 pe...
Alison Jaworski,Carleigh Cowling,Gordana Popovic et al.
Alison Jaworski et al.
Trachoma is the world's leading infectious cause of preventable blindness and is linked to poor living conditions. In Australia, trachoma has remained a public health problem in remote Indigenous communities in northern, central, and wester...
Investigation of a norovirus outbreak at a catered social event, Australian Capital Territory, 2024 [0.03%]
2024年澳大利亚首都领地一起由诺如病毒引起的宴会暴发事件调查
Clare Kinnear,Timothy Sloan-Gardner,Natasha Waters et al.
Clare Kinnear et al.
Background: An outbreak of gastrointestinal illness was notified, affecting attendees at a private function in the Australian Capital Territory (ACT) in 2024. Investigations were conducted to determine the infectious agen...
Measles epidemiology in Australia: 2014 to 2024. Erratum to 10.33321/cdi.2026.50.016 [0.03%]
澳大利亚 measles 流行病学：2014 至 2024 年 纠正：10.33321/cdi.2026.50.016
Lizzie Gorrell,Benjamin Polkinghorne,David Durrheim
Lizzie Gorrell
This article, as originally published, contained a mis-compiled tabulation of the notified measles clusters within Australia for the period 2014-2024, inadvertently misrepresenting the distribution of measles clusters across the country dur...
Published Erratum
Communicable diseases intelligence (2018). 2026 Jun 16:50. DOI:10.33321/cdi.2026.50.048 2026
Presymptomatic transmission, vaccine breakthrough and anonymous contacts: a cluster of mpox in Canberra, Australian Capital Territory, 2024 [0.03%]
无症状传播、疫苗突破和匿名接触者：2024年澳大利亚首都直辖区堪培拉猴痘群集事件
Alexandra Marmor,Rachael Crane,Felicity Greenville et al.
Alexandra Marmor et al.
This report outlines a localised cluster of mpox detected in July 2024, in Canberra, Australian Capital Territory. Investigation identified nine cases, including likely presymptomatic transmission by a vaccinated primary case with a high-co...
The Strategic Plan for Tuberculosis Elimination and Equity in Australia 2026-2030 [0.03%]
《2026—2030年澳大利亚消除结核病和实现公平的战略规划》
National Tuberculosis Advisory Committee,Justin Denholm
National Tuberculosis Advisory Committee
The Strategic Plan for Tuberculosis Elimination and Equity in Australia, 2026-2030 provides the framework for Australia's tuberculosis (TB) programmatic response over the next five years. The Strategic Plan upholds a focus on achieving TB e...